Maghzi, Amir Hadi
Houtchens, Maria K.
Preziosa, Paolo
Ionete, Carolina
Beretich, Biljana D.
Stankiewicz, James M.
Tauhid, Shahamat
Cabot, Ann
Berriosmorales, Idanis
Schwartz, Tamara H. W.
Sloane, Jacob A.
Freedman, Mark S.
Filippi, Massimo
Weiner, Howard L.
Bakshi, Rohit http://orcid.org/0000-0001-8601-5534
Funding for this research was provided by:
National Multiple Sclerosis Society
American Brain Foundation
Article History
Received: 1 May 2020
Revised: 18 May 2020
Accepted: 20 May 2020
First Online: 3 June 2020
Compliance with ethical standards
:
: MK Houtchens has received consulting fees from Biogen, EMD Serono, Sanofi-Genzyme, Mallinckrodt, Roche and research support from Biogen, EMD Serono, and Sanofi-Genzyme. P Preziosa has received speaking fees from Biogen, ExceMED, Merck Serono, and Novartis. C Ionete has received consulting fees from Sanofi-Genzyme, and research support from Biogen, EMD Serono, and Genentech. JM Stankiewicz has received consulting fees from Biogen, BMS/Celgene, EMD Serono, Genentech, Sanofi-Genzyme, and Novartis. A Cabot has received speaking fees from Alexion, Biogen, EMD/Serono, Genentech, Novartis, and Sanofi-Genzyme. JA Sloane has received consulting fees from Biogen, BMS/Celgene, EMD Serono, Genentech, Alexion, and Sanofi-Genzyme, and research support from National MS Society, Genentech, Biogen, EMD Serono, and Sanofi-Genzyme. MS Freedman has received research or educational grants from EMD Serono, Hoffman-La Roche, and Sanofi-Genzyme, and honoraria, consultation, or speaking fees from Actelion, Alexion, Atara, Bayer, Biogen, BMS/Celgene, Clene Nanomedicine, EMD Serono, GRI Bio, Hoffman La-Roche, Magenta Therapeutics, MedDay, Merck Serono, Novartis, Sanofi-Genzyme, and Teva. M Filippi has received consulting and/or speaking fees from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva, and research support from Biogen, Merck-Serono, Novartis, Roche, and Teva. HL Weiner has received consulting fees from Biodextris, Biogen, CBridge Capital, Everest Medicines, Genentech, Tiziana, Tilos, IM Therapeutics, Magnolia, MedDay, and vTv, and research support from Biogen, EMD Serono, Genentech, Sanofi-Genzyme, Google, Novartis; Teva, Tilos, and Verily. R Bakshi has received consulting fees from Bayer, Biogen, BMS/Celgene, EMD Serono, Genentech, and Novartis, and research support from BMS/Celgene, EMD Serono, and Sanofi-Genzyme. The other authors have nothing to disclose.
: All patients provided consent to be anonymously included in this report.
: All authors have consented to publication.
Free to read: This content has been made available to all.